Skip to Main Content

Author Details

Francisco Vega
The University of Texas MD Anderson Cancer Center
1996
303
52
PMIDPaper TitleJournal TitlePublished Year
34175178Aggressive Mediastinal Lymphomas.Semin Diagn Pathol2024
36375046A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.Blood Adv2023
37662289Progressive plasticity during colorectal cancer metastasis.bioRxiv2023
38007239Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.J Immunother Cancer2023
37586321Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.Cell Rep Med2023
37948938Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167].Mod Pathol2023
37649813Correction: The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.Cancer Res Commun2023
37821434Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma.Blood Cancer J2023
37603594Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.Blood Adv2023
37190143Rectal Cancer after Prostate Radiation: A Complex and Controversial Disease.Cancers (Basel)2023
37288826Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features.Am J Surg Pathol2023
37084736Genomic mapping of metastatic organotropism in lung adenocarcinoma.Cancer Cell2023
37014044Correction: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.Cancer Res2023
37311462Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination.Mol Cell2023
37468552Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.Leukemia2023
37200093The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression.J Clin Invest2023
36994939CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapy.Histopathology2023
36567046Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma.Cardiovasc Pathol2023
36633881ALK-positive large B-cell lymphoma, a rare B-cell lymphoma expressing ALK.Blood2023
36566629Clinical impact of 5<sup>'</sup>MYC or 3<sup>'</sup>MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas.Cancer Genet2023
36941707PD-L1<sup>+</sup> macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma.Exp Hematol Oncol2023
36793612Pathologic and molecular insights in nodal T-follicular helper cell lymphomas.Front Oncol2023
36453104<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.Haematologica2023
36171662A methylation-based prognostic signature in stage II colorectal patients: Considerations for clinical adoption.J Natl Cancer Inst2023
36325892Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma.Haematologica2023
35952327Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.J Clin Oncol2023
34767860Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.Hum Pathol2022
35740600ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment.Cancers (Basel)2022
35705560Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.Nat Commun2022
35474464CD70 is a potential target biomarker in peripheral T-cell lymphomas.Histopathology2022
35732829The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia2022
35575765Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.Am J Surg Pathol2022
35394541KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer.Mol Cancer Res2022
35718564Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort study.Br J Anaesth2022
35817594Childhood lymphomatoid papulosis Type D, a rare and challenging diagnosis.Pediatr Dermatol2022
35687817Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.Blood Cancer Discov2022
35359004SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab.Blood Adv2022
35622145CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma.Virchows Arch2022
35970919Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.Nat Med2022
35896920Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.Ann Surg Oncol2022
35864006Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms.Pathology2022
36197962A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos.Sci Transl Med2022
35881486Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses.J Clin Invest2022
35074072Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (⿤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.Lancet Oncol2022
35066956Computational methods and translational applications for targeted next-generation sequencing platforms.Genes Chromosomes Cancer2022
35066881Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.J Surg Oncol2022
35142847Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies.Blood2022
34969327Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma.Leuk Lymphoma2022
35235413Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.JCO Precis Oncol2022
35299081From the archives of MD Anderson Cancer Center: Intravascular large B-cell lymphoma with numerous circulating lymphoma cells.Ann Diagn Pathol2022
  • 1 - 50 of 303

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 3
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Career Start Year 2012
Number of shared co-authors 2
Gareth P Gregory
School of Clinical Sciences at Monash Health, Monash University
Career Start Year 2011
Number of shared co-authors 2
David Wu
University of Washington
Career Start Year 2010
Number of shared co-authors 7
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 6
Jeremy C Wallentine
Intermountain Medical Center
Career Start Year 2007
Number of shared co-authors 0
Shirin Karimi
Princess Margaret Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 11
Melissa H Cessna
Intermountain Medical Center
Career Start Year 2001
Number of shared co-authors 0
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Ralf Kemmerling
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 0
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 3
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 1
Sze Fai Yip
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 5
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 3
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 23
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Nicholas Sioutos
Center for Biomedical Informatics & Information Technology, National Cancer Institute
Career Start Year 1991
Number of shared co-authors 1
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 4
Kim E Nichols
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 7
Louis M Staudt
National Cancer Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 23
David M Dorfman
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 8
Sherrie L Perkins
University of Utah
Career Start Year 1982
Number of shared co-authors 3
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 2
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 5
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 10
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 1
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Career Start Year 1979
Number of shared co-authors 9
Dennis B Cornfield
Lehigh Valley Hospital
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 41
Walid K Chatila
Memorial Sloan Kettering Cancer Center
Co-authored papers 17
Michael F Berger
Co-authored papers 14
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 14
Pei Lin
Co-authored papers 12
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Linghua Wang
The University of Texas M. D. Anderson
Co-authored papers 8
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 8
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 7
Ronglai Shen
Co-authored papers 6
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Peter W Laird
Van Andel Institute
Co-authored papers 6
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Hira Rizvi
Druckenmiler Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Vasileios Stathias
Co-authored papers 5
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Co-authored papers 5
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Matthew Meyerson
Broad Institute
Co-authored papers 4
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers 4
Reanne Bowlby
Co-authored papers 4
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Vesteinn Thorsson
Institute for Systems Biology
Co-authored papers 4
Ronan Swords
Oregon Health and Science University
Co-authored papers 4
Chris Sander
Broad Institute of MIT and Harvard
Co-authored papers 4
Giovanni Ciriello
University of Lausanne (UNIL)
Co-authored papers 4
Release 1.2